Brian Sullivan is co-anchor of CNBC's "Power Lunch" (M-F,1PM-3PM ET), one of the network's longest running programs, as well as the host of the daily investing program "Trading Nation." He is also a frequent guest on MSNBC's "Morning Joe" and other NBC properties.
In his 20 years of financial journalism and television experience, Sullivan has reported from five continents. He has been twice nominated for the prestigious Loeb Award; one for being recognized as among the first financial journalists to highlight the risks of the housing bubble in 2007, and the other for the 2013 CNBC documentary "America's Gun: The Rise of the AR-15."
Prior to CNBC, Sullivan served as an anchor at Fox Business News as well as a producer, reporter and anchor for Bloomberg Television.
Sullivan has a B.A. in political science from Virginia Tech, where he serves on the Alumni Board, as well as a law degree from Brooklyn Law School. In his free time he is an avid race car driver with two SCCA divisional championships.
Heather Bresch, Mylan CEO, says the fight is on to fix the health care system and she is willing to work with Congress to make it happen.
Heather Bresch, Mylan CEO, says the health care system is broken and if you don't play in the system your products won't get to patients.
Heather Bresch, Mylan CEO, urges changes to update the U.S. health care system and talks about the need to bring down drug costs. Patients are paying twice, says Bresch.
Heather Bresch, Mylan CEO, discusses the need to update the U.S. health care system, and the company's plan to provide an alternate route on pricing.
Heather Bresch, Mylan CEO talks about her frustration with the rising price of drugs.
Heather Bresch, Mylan CEO breaks down the pricing path of the EpiPen and the company's plan to expand access to the drug.
Heather Bresch, Mylan CEO, responds to the controversy surround the company's 400-percent increase for its injectable allergy medicine.
In a wide-ranging interview, Heather Bresch, Mylan CEO sits CNBC's Brian Sullivan to discuss the controversy surround the recent 400-percent increase in the EpiPen and her frustration with the health care system.
With low volatility and low volume, how can investors make money in today’s market? Gina Sanchez of Chantico Global and Phillip Streible of RJO Futures discuss with Brian Sullivan.
The chart of oil shows a big rally this year, so why is oil ETF USO down? Phillip Streible of RJO Futures and Gina Sanchez of Chantico Global discuss with Brian Sullivan.
The president just got 'rolled' by his own party, one political veteran told CNBC.
House Democratic Whip Steny Hoyer told CNBC on Friday he doesn't blame Americans who may have lost faith in Congress, because he feels their pain.
The issue at stake is not just the fate of a single company, but the fate of capitalism itself, says Bill George.
These are Macy's three main problems, according to senior retail analyst Oliver Chen.